InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Brinkley Ruth Williams, Director. Director active across 1 companies, notably Travere Therapeutics, Inc.. Cumulatively, 3 reports have been published. The latest transaction was disclosed on 11 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
03,000 shares0
Common Stock
SEC:0001209191-22-028704:0·
05,250 shares0
Common Stock
SEC:0001209191-21-056459·
05,250 shares0
Common Stock
SEC:0001209191-21-056459:0·
3 of 3 declarations
About Brinkley Ruth Williams
Ruth Williams Brinkley is a Board Member at Travere Therapeutics, Inc. She plays a crucial role in overseeing the company's activities and making strategic decisions. With her experience in the industry, she contributes to implementing effective governance practices and achieving the company's objectives. Her commitment to innovation and corporate social responsibility is a valuable asset to the board.
